Related references
Note: Only part of the references are listed.The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action
D. M. Kerr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum
Katina S. S. Dossou et al.
JOURNAL OF NATURAL PRODUCTS (2013)
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
Sudeshna Ghosh et al.
LIFE SCIENCES (2013)
Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
Lei Gu et al.
PLOS ONE (2013)
Redundancy of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
Fabiana Piscitelli et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents
Kwong-Fai Wong et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk
Siddaraju M. Nanjundaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: The involvement of cannabinoid system
Rafael Cypriano Dutra et al.
NEUROPHARMACOLOGY (2012)
Dynamic changes to the endocannabinoid system in models of chronic pain
Devi Rani Sagar et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Radhamani Kannaiyan et al.
CANCER LETTERS (2011)
The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
L. J. Alvarez-Jaimes et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Celastrus-derived Celastrol Suppresses Autoimmune Arthritis by Modulating Antigen-induced Cellular and Humoral Effector Responses
Shivaprasad H. Venkatesha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
Daniel Paris et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Ralf Baron et al.
LANCET NEUROLOGY (2010)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Alvin R. King et al.
CHEMISTRY & BIOLOGY (2009)
Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model
Dae Yong Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse
Anne-Frederique Bourquin et al.
PAIN (2006)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice
TM Cunha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Spared nerve injury model of neuropathic pain in the mouse: A behavioral and anatomic analysis
SD Shields et al.
JOURNAL OF PAIN (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Observation on serum anti-double stranded DNA antibodies of tripterine in systemic lupus erythematosus of (NZBxW)F1 mice
X Xu et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
ASC Rice et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease
AC Allison et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)
Are cannabinoids an effective and safe treatment option in the management of pain?: A qualitative systematic review
FA Campbell et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
